Clinical Significance of CCR4 Expression in Adult T-Cell Leukemia/Lymphoma: Its Close Association with Skin Involvement and Unfavorable Outcome

Clinical Cancer Research

Volumn 9, Issue 10, 2003, Pages 3625-3634

  Ishida, Takashi ^a   Utsunomiya, Atae ^b   Iida, Shinsuke ^a   Inagaki, Hiroshi ^a   Takatsuka, Yoshifusa ^b   Kusumoto, Shigeru ^c   Takeuchi, Genji ^c   Shimizu, Shigeki ^a   Ito, Masato ^a   Komatsu, Hirokazu ^a   Wakita, Atsushi ^d   Eimoto, Tadaaki ^a   Matsushima, Kouji ^e   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Imamura Bun in Hospital   (Japan)

^c SHIZUOKA SAISEIKAI GENERAL HOSPITAL   (Japan)

^d NAGOYA CITY UNIVERSITY HOSPITAL   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; PRIORITY JOURNAL; PROGNOSIS; SKIN DISEASE; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CHEMOKINES, CC; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, T-CELL; LIGANDS; LYMPH NODES; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PROGNOSIS; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 12444272236     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Zlotnik, A., and Yoshie, O. Chemokines: a new classification system and their role in immunity. Immunity, 12: 121–127, 2000.
2. Campbell, J. J., and Butcher, E. C. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol., 12: 336–341, 2000.
3. Bucher, E. C., Williams, M., Youngman, K., Rott, L., and Briskin, M. Lymphocyte trafficking and regional immunity. Adv. Immunol., 72: 209–253, 1999.
4. Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Brrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond.), 410: 50–56, 2001.
5. Kikuchi, M., Jaffe, E. S., and Ralfkiaer, E. Adult T-cell leukaemia/lymphoma. In: E. S. Jaffe, N. L. Harris, H. Stein, and J. W. Vardiman (eds.), Pathology and Genetics Tumors of Haematopoietic and Lymphoid Tissues, pp. 200–203, Lyon, France: IARC Press, 2001.
6. Uchiyama, T. Human T cell leukemia virus type 1 (HTLV-1) and human diseases. Annu. Rev. Immunol., 15: 15–37, 1997.
7. Qin, S., Rottmann, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., and Mackay, C. R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Investig., 101: 746–754, 1998.
8. Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., and Sinigaglia, F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med., 187: 129–134, 1998.
9. D'Ambrosio, D., Iellem, A., Bonecchi, R., Mazzeo, D., Sozzani, S., Mantovani, A., and Sinigaglia, F. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol., 161: 5111–5115, 1998.
10. Zingoni, A., Soto, H., Hedrick, J. A., Stoppacciaro, A., Storlazzi, C. T., Sinigaglia, F., D'Ambrosio, D., O'Garra, A., Robinson, D., Rocchi, M., Santoni, A., Zlotnik, A., and Napolitano, M. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol., 161: 547–551, 1998.
11. Yamamoto, J., Adachi, Y., Onoue, Y., Adachi, Y. S., Okabe, Y., Itazawa, T., Toyoda, M., Seki, T., Morihashi, M., Matsushima, K., and Miyawaki, T. Differential expression of the chemokine receptors by the Th1-and Th-2 type effector populations within circulating CD4+ T cells. J. Leuk. Biol., 68: 568–574, 2000.
12. Andrew, D. P., Ruffing, N., Kim, C. H., Miao, W., Heath, H., Li, Y., Murphy, K., Campbell, J. J., Butcher, E. C., and Wu, L. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J. Immunol., 166: 103–111, 2001.
13. Jones, D., O'Hara, C., Kraus, M. D., Perez-Atayde, A. R., Shahsafaei, A., Wu, L., and Dorfman, D. M. Expression pattern of T-cellassociated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood, 96: 685– 690, 2000.
14. Imai, T., Nagira, M., Takagi, S., Kakizaki, M., Nishimura, M., Wang, J., Gray, P. W., Matsushima, K., and Yoshie, O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol., 11: 81–88, 1999.
15. Jones, D., Benjamin, R. J., Shahsafaei, A., and Dorfman, D. M. The chemokine receptor CXCR3 is expressed in a subset of B cells and is a marker for B-cell chronic lymphocytic leukemia. Blood, 95: 627–632, 2000.
16. Duijvestijn, A. M., Horst, E., Pals, S. T., Rouse, B. N., Steere, A. C., Picker, L. J., Meijer, C. J., and Butcher, E. C. High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am. J. Pathol., 130: 147–155, 1988.
17. Naoe, T., Akao, Y., Yamada, K., Utsumi, K. R., Koike, K., Shamoto, M., Koike, K., Kurosawa, Y., Kato, K., Abe, M., and Shiku, H. Cytogenetic characterization of a T-cell line, ATN-1, derived from adult T-cell leukemia cells. Cancer Genet. Cytogenet., 34: 77–88, 1988.
18. Gazdar, A. F., Carney, D., Bunn, P. A., Russell, E. K., Jaffe, E. S., Schechter, G. P., and Guccion, J. G. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood, 55: 409–417, 1980.
19. Bunn, P. A., and Foss, F. M. T-Cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cytaneous T-cell lymphomas (CTCL) and adult T-cell leukemialymphomas (ATLL). J. Cell. Biochem. Suppl., 24: 12–23, 1996.
20. Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., and Hinuma, Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature (Lond.), 294: 770–771, 1981.
21. Schauer, U., Jung, T., Krug, N., and Frew, A. Measurement of intracellular cytokines. Immunol. Today, 17: 305–306, 1996.
22. Ponte, P., Ng, S. Y., Engle, J., Gunning, P., and Kedes, L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequences of a human β-actin cDNA. Nucleic Acids Res., 12: 1687–1696, 1984.
23. Shimoyama, M., and members of the Lymphoma Study Group (1984–1987). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br. J. Haematol., 79: 428–437, 1991.
24. Uozumi, K., Hanada, S., Ohno, S., Ishitsuka, K., Shimotakehara, S., Otsuka, M., Chyuman, Y., Nakahara, K., Takeshita, T., Kuwazuru, Y., Saito, T., Makino, T., Iwahashi, M., Utsunomiya, A., and Arima, T. Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia. Leuk. Lymphoma, 18: 317–323, 1995.
25. Yamada, Y., Tomonaga, M., Fukuda, H., Hanada, S., Utsunomiya, A., Tara, M., Sano, M., Ikeda, S., Takatsuki, K., Kozuru, M., Araki, K., Kawano, F., Niimi, M., Tobinai, K., Hotta, T., and Shimoyama, M. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br. J. Haematol., 113: 375–382, 2001.
26. Sagawa, K., Mochizuki, M., Katagiri, K., Tsuboi, I., Sugita, S., Mukaida, N., and Itoh, K. In vitro effects of immunosuppressive agent on cytokine production by HTLV-1-infected T cell clones derived from the ocular fluid of patients with HTLV-1 uveitis. Microbiol. Immunol., 40: 373–379, 1996.
27. Yamada, Y., Ohmoto, Y., Hata, T., Yamamura, M., Murata, K., Tsukasaki, K., Kohno, T., Chen, Y., Kamihira, S., and Tomonaga, M. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk. Lymphoma, 21: 443–447, 1996.
28. Tanaka, Y., Wake, A., Kevin, J. H., Murakami, S., Aso, M., Saito, K., Oda, S., Morimoto, I., Uno, H., Kikuchi, H., Izumi, Y., and Eto, S. Distinct phenotype of leukemic T cells with various tissues tropisms. J. Immunol., 158: 3822–3829, 1997.
29. Ohtsuka, E., Kikuchi, H., Nasu, M., Takita-Sonoda, Y., Fujii, H., and Yokoyama, S. Clinicopathological features of adult T-cell leukemia with CD30 antigen expression. Leuk. Lymphoma, 15: 303–310, 1994.
30. Yoshie, O., Fujisawa, R., Nakayama, T., Harasawa, H., Tago, H., Izawa, D., Tatsumi, Y., Matsushima, K., Hasegawa, H., Kanamaru, A., Kamihira, S., and Yamada, Y. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood, 99: 1505–1511, 2002.
31. Hasae, K., Tani, K., Shimizu, T., Ohmoto, Y., Matsushima, K., and Sone, S. Increased CCR4 expression in active systemic lupus erythematosus. J. Leuk. Biol., 70: 749–755, 2001.
32. Nakatani, T., Kaburagi, Y., Shimada, Y., Inaoki, M., Takehara, K., Mukaida, N., and Sato, S. CCR4+ memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J. Allergy Clin. Immunol., 107: 353–358, 2001.
33. Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S., and Yoshie, O. The T-cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem., 272: 15036–15042, 1997.
34. Campbell, J. J., Haraldsen, G., Pan, J., Rottmann, J., Qin, S., Ponath, P., Andrew, D. P., Warnke, R., Ruffing, N., Kassam, N., Wu, L., and Butcher, E. C. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature (Lond.), 400: 776–780, 1999.
35. Kunkel, E. J., Boisvert, J., Murphy, K., Vierra, M. A., Genovese, M. C. Wardlaw, A. J., Greenberg, H. B., Hodge, M. R. Wu, L., Butcher, E. C., and Campbell, J. J. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol., 160: 347–355, 2002.
36. Ruckes, T., Saul, D., Snick, J. V., Hermine, O., and Grassman, R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood, 98: 1150–1159, 2001.
37. Kijima, T., Gautam, M., Patrick, C. M., Elena, V., Tibaldi, R. E., Turner, B. R., Martin, S., Bruce, E. J., and Ravi, S. N. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-kit in small cell lung cancer cells. Cancer Res., 62: 6304–6311, 2002.